Chemical can reproduce complications for som... ( BETHESDA Md. (May 1 2009) − Me...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Chemical can reproduce complications for some patients

Date:4/30/2009

BETHESDA, Md. (May 1, 2009) − Medical science took a giant leap forward with the development of techniques that, at least temporarily, perform the function of vital organs. These processes, including the use of the heart-lung machine and renal dialysis, require the blood to be circulated through tubing outside the body and are hence known as extracorporeal circulation (EC) and have provided critical life support for millions of patients. Yet EC is not without its own risks. Among them are unique morbidities such as depressed cardiac output, abnormal heart rhythm, and swelling of the major organs. Studies have been conducted for decades to determine how these effects can be reduced and eliminated. In a new study conducted by a Johns Hopkins team, the researchers examined whether a solvent used in the production of intravenous (IV) bags and EC circuits could play a role. Their results indicate that 1) the solvent cyclohexanone (CHX) can leach into IV and EC fluids, and 2) CHX administered in controlled doses in an animal model replicates the cardiovascular and lung morbidities that are seen in patients during and after EC treatment. The study sheds new light on the potential causes of EC-related disorders.

The study was conducted by Caitlin S. Thompson-Torgerson and Lakshmi Santhanam, Department of Biomedical Engineering; Hunter C. Champion, Department of Medicine (Division of Cardiology); Z. Leah Harris, Department of Anesthesiology and Critical Care Medicine; and Artin A. Shoukas, Departments of Biomedical Engineering, Anesthesiology and Critical Care Medicine, and Physiology, The Johns Hopkins University School of Medicine, Baltimore, MD. The study, entitled Cyclohexanone Contamination From Extracorporeal Circuits Impairs Cardiovascular Function, is published in the online edition of the American Journal of PhysiologyHeart and Circulatory Physiology.

The Study

Cyclohexanone (CHX) is an organic solvent widely used i
'/>"/>

Contact: Donna Krupa
DKrupa@the-aps.org
301-634-7209
American Physiological Society
Source:Eurekalert

1

GOOD

Page: 1 2 3 4 5
Related medicine news :

1. USC Chemical Engineer Launches Virucide, Bactericidal That Can Kill 99.9% of Germs and Help Combat Swine Flu
2. Wayne State University and Childrens Hospital of Michigan Research Team Discover Chemical That Plays a Major Role in Pediatric Obsessive-Compulsive Disorder
3. New Federal Legislation Targets Toxic Chemicals in Baby Bath Products
4. N. California Researchers Testing Whether Marijuana Chemical Can Slow Cancer Growth, With Funding by Susan G. Komen for the Cure(R)
5. Soybean Chemicals May Reduce Effects of Menopause
6. Common Industrial Chemicals May Not Boost Cancer Risk
7. Cancer-Causing Toxins Detected in Fluoride Chemicals, Says NYS Coalition Opposed to Fluoridation
8. BioMosaics Glypican-3 Antibody (clone 1G12) Validated at PhenoPath Laboratories for Immunohistochemical Detection of Liver Cancer
9. Gulf War Syndrome May Stem From Chemical Exposure
10. NovaBay Pharmaceuticals Scientific Advisor Receives American Chemical Societys Highest Award
11. Toxic Chemicals in Childrens Bath Products Trigger International Outcry

Post Your Comments:

[0] Soy Beneficial for Breast Cancer Survivors: Study [1] Researchers Use New Techniques to Assess PTSD [0] Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries)[1] Patient Safety Organization (PSO) Participation: What Every Provider Needs to Know [1] Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends)

Other Medicine News:Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 2 Health News:Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex 3 Health News:Stigma Keeps Teens From Depression Treatment 2 Health News:The Ottawa Hospital Transforms Procurement and Spend Management with the Oracle(R) E-Business Suite 2 Health News:The Ottawa Hospital Transforms Procurement and Spend Management with the Oracle(R) E-Business Suite 3 Health News:The Ottawa Hospital Transforms Procurement and Spend Management with the Oracle(R) E-Business Suite 4 Health News:Gyminee Raises 525K and Relaunches as DailyBurn 2 Health News:Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking? 2 Health News:Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking? 3 Health News:Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking? 4 Health News:Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking? 5 Health News:Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making 2 Health News:Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making 3

Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex Stigma Keeps Teens From Depression Treatment The Ottawa Hospital Transforms Procurement and Spend Management with the Oracle(R) E-Business Suite Gyminee Raises 525K and Relaunches as DailyBurn Multiple Sclerosis - What Are People With MS and Their Health Care Providers Really Thinking?Carefx's Newest White Paper Illuminates Healthcare CIOs' Growing Role in Operations, Strategic Thinking and IT Project Decision Making

Breaking Medicine Technology:Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 2 Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 3 Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 4 Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities 5 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 2 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 3 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 4 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 5 Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 6 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 2 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 3 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 4 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 5 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 6 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 7 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 8 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 1 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 2 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 3 Partnership for Prescription Assistance Prepared to Help South Dakota Workers Hurt by Recession 50098 4 New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents 50095 1 New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents 50095 2 10 students receive scholarships for outstanding work in public health systems research 50092 1

[0] Reportlinker Adds Bulk Paclitaxel - A Global Update of Market Trends & Opportunities [0] Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 [0] Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective

Other Medicine Technology:XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 2 XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 3 XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 4 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 2 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 3 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 4 XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years 5

XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years

Medicine Products:

STA STACHROM PROTEIN C ASSERACHROM PROTEIN C STA ROTACHROM HEPARIN 4 STA DEFICIENT X

Chemical can reproduce complications for som...( BETHESDA Md. (May 1 2009) − Me...),Health